In summary, our experimental results showed that GAs could prevent RIRI-induced AKI by inhibiting the activation of TLR4 and MyD88, which further prevent the initiation of downstream inflammatory response and cell apoptosis pathway, eventually improving renal function for the first time. Here, MYD88 is linked to acute kidney injury.